Rx Drug News

Complete Archives

2015 December
- Lifestyle switching - Bacillus cereus is able to resist certain antibiotic therapies
2015 August
- One in four hepatitis C patients denied initial approval for drug treatment
2015 July
- FDA strengthens warning label for certain anti-inflammatory drugs
2015 June
- New target may increase odds of successful mosquito-based malaria vaccine
- Study shows first signs that ADHD drug may improve cognitive difficulties in menopausal women
2015 May
- Anti-stroke drug effective treatment for middle-ear infections, researchers say
- Dasabuvir in hepatitis C: Indication of added benefit in certain patients
- U.S. FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug
2015 April
- Study tallies huge cost of hepatitis C drugs for RI prisons
- Drug regulations tied to fewer prescriptions of effective gout drug
- Open-angle glaucoma: Poor data for the fixed combination tafluprost/timolol
- Statistical analysis reveals Mexican drug war increased homicide rates
2015 February
- Evolution may hold the key to more designer cancer drugs like Gleevec
- Violations in pharmaceutical industry self-regulation of medicines promotion
- UCSF-led study shows why some targeted cancer drugs lose effectiveness
2015 January
- Are medications’ adverse cognitive effects reversible?
- Prescription painkillers, widely used by childbearing age women, double birth defects risk
- New ‘triggered-release’ mechanism could improve drug delivery
2014 October
- Added benefit of vedolizumab is not proven
2014 July
- Anti-inflammatory drug can prevent neuron loss in Parkinson’s model
- EORTC presents European solution for effective cancer drug development
2014 June
- FDA lifts hold on Achillion’s hepatitis C drug, shares jump
- Anti-diabetic drug slows aging and lengthens lifespan
2014 May
- U.S. FDA approves Durata’s acute bacterial skin infection drug
- Qiagen wins U.S. approval for test to accompany Amgen cancer drug
- Endocyte’s ovarian cancer drug fails trial, shares sink
- Acorda Therapeutics says FDA rejects epilepsy drug
2014 April
- Bayer may sell plastics unit to focus on health: Bloomberg
- Actavis sues U.S. drug regulator over generic Celebrex
- Study recalculates cost of combination vaccines
- Intercept’s liver disease drug proves highly effective in study
- J&J says halting development of Botox rival
- Texas Medicaid holds off on proposed limits for Gilead hepatitis drug
2014 March
- Italian prosecutors open probe against Roche, Novartis
2014 February
- FDA approves Anika Therapeutics arthritis drug; shares soar
- FDA approves Bristol-Myers drug for rare body fat disorder
- Afatinib: added benefit depends on mutation status
- Unusual new HIV drug resistance mechanism revealed
- FDA warns about Medisca’s L-citrulline supplement
- FDA Restricts Access to Rosiglitazone, EMEA Recommends Suspension
- Roche bans rivals from comparing copycat drugs to Herceptin
- FDA asks for more trials of Sprout’s drug for low female libido
2014 January
- EU panel recommends suspension of risky bone disease drug
- Long-term efficacy of Chelsea drug may pose problems for FDA
- Teriflunomide in multiple sclerosis: added benefit not proven
2013 December
- Antioxidant drug knocks down multiple sclerosis-like disease in mice
- U.S. FDA approves Novo Nordisk’s drug for rare blood clotting disorder
- Ariad to resume sales of cancer drug Iclusig, shares jump
- U.S. lifts sanction on a CVS Caremark Medicare drug plan
- Bristol close to selling diabetes stake to Astra for $3 billion: WSJ
- FDA staff cautious on AstraZeneca, Bristol diabetes drug
- U.S. FDA panel to review Oralair for approval: documents
- FDA looks again at Boston Scientific anti-stroke device
- Novel drug regimen can improve stem cell transplantation outcomes
- Added benefit of saxagliptin as monotherapy is not proven
- OncoMed stock doubles after cancer drug deal with Celgene
- Novo confident of strong drug pipeline and future growth- CEO
- New data backs promise of long-acting Sanofi insulin
- The importance of standardizing drug screening studies
2013 November
- NIH-funded scientists identify potential target for malaria drugs
- FDA Opens Door to Wider Avandia Prescribing
- New HCV Drug Approved
- FDA lifts constraints on Glaxo diabetes drug Avandia
- Acne drug users need to know birth control options: study
- U.S. FDA approves Bayer/Onyx drug for a type of thyroid cancer
- Targets of anticancer drugs have broader functions than what their name suggests
- ‘Undruggable’ mutation meets its match
- Amgen cholesterol drug appears safe, cut LDL 52 percent at 1 year: study
- GlaxoSmithKline’s asthma drug Relvar approved in Europe
- Horizon Pharma to buy U.S. rights to AstraZeneca’s arthritis drug
- Drug offers promising approach to improve outcome for children with high-risk leukemia
- U.S. health regulators approve J&J, Pharmacyclics lymphoma drug
- GlaxoSmithKline heart drug misses goal in major study
- U.S. FDA approves Sunovion Pharmaceuticals’ seizure drug
- FDA approves Aptiom to treat seizures in adults
- New Roche leukemia drug shows clear advantage over Rituxan: study
- Geron cancer drug effective in trial, shares soar
- McMaster scientists unlock secrets of diabetes drug
- FDA approves Roche leukemia drug Gazyva
2013 October
- Celgene arthritis drug appears effective, safe after one year: study
- FDA panel backs Gilead hepatitis C drug sofosbuvir
- New group of oral hepatitis C drugs near U.S. approval
- Want data on drugs? Look for clinical study reports
- Bribery scandal slashes GlaxoSmithKline’s Chinese drug sales
- Actelion hits six-year high after favorable FDA approval for drug
- U.S. FDA panel backs Paladin Labs’ parasitic disease drug
- FDA Approves New Pulmonary Hypertension Drug From Actelion
- FDA Approves Novo Nordisk’s NovoEight
- Regeneron, Sanofi drug slashes cholesterol in late-stage trial
- Cancer Drug Still Out of Reach for Denver Dad
- Gilead drug works against leukemia, trial stopped early
- Pfizer drug shows mixed results in psoriasis trials
- FDA OKs New Drug for Pulmonary Hypertension
- Novartis says drug reduces itch of severe chronic hives
- FDA approves Baxter’s intravenous nutritional supplement
- McMaster lab develops new tuberculosis vaccine
2013 September
- Japan approves lung drugs from GSK/Theravance and SkyePharma
- Sanofi in $40 million settlement over obesity drug linked to suicidal thoughts
- Biologists develop new method for discovering antibiotics
- Sanofi could acquire L’Oreal’s stake, buy more of Regeneron

Subscribe to the "News" RSS Feed

TOP ۞

Lifestyle switching - Bacillus cereus…
The bacterium B. cereus had so far been considered to…
One in four hepatitis C…
Nearly one in four patients with chronic hepatitis C (HCV)…
FDA strengthens warning label for…
The U.S. food and Drug Administration said it was strengthening…
New target may increase odds…
Researchers from the Johns Hopkins Bloomberg School of Public Health…
Study shows first signs that…
According to a new study, women experiencing difficulty with time…
Anti-stroke drug effective treatment for…
An existing anti-stroke drug is an effective treatment for middle-ear…
Dasabuvir in hepatitis C: Indication…
The drug dasabuvir (trade name Exviera) has been available since…
U.S. FDA approves Glaxo, Theravance’s…
The U.S. Food and Drug Administration on Thursday approved the…
Study tallies huge cost of…
A new study finds that effective new hepatitis C drugs…
Drug regulations tied to fewer…
Well intentioned, but costly and potentially problematic. That’s how researchers…

About Us | Privacy Policy | Terms of Use | Contact Us

© 2012 RxDrug News 1999-2016. All rights reserved